tiprankstipranks
Advertisement
Advertisement

MIRM Stock Latest News

Mirum Pharmaceuticals price target raised to $150 from $140 at Morgan Stanley
The FlyMirum Pharmaceuticals price target raised to $150 from $140 at Morgan Stanley
1d ago
VIR
MIRM
Vir Biotechnology price target raised to $27 from $23 at Morgan Stanley
PremiumThe Fly
Vir Biotechnology price target raised to $27 from $23 at Morgan Stanley
1d ago
VIR
MIRM
Incyte, Mirum to present Phase 2 results from PROGRESS study at ENDO 2026
PremiumThe Fly
Incyte, Mirum to present Phase 2 results from PROGRESS study at ENDO 2026
8d ago
INCY
MIRM
Mirum Expands Long-Term Safety Data for Livmarli in Rare Pediatric Liver Diseases
PremiumCompany Announcements
Mirum Expands Long-Term Safety Data for Livmarli in Rare Pediatric Liver Diseases
9d ago
MIRM
Mirum Pharmaceuticals initiated with a Buy at Citi
PremiumThe Fly
Mirum Pharmaceuticals initiated with a Buy at Citi
10d ago
MIRM
Mirum Pharma Earns Buy Rating on Strong Volixibat Phase 2b PSC Data and De-Risked Regulatory Path
PremiumRatingsMirum Pharma Earns Buy Rating on Strong Volixibat Phase 2b PSC Data and De-Risked Regulatory Path
12d ago
MIRM
Mirum announces new data from its rare liver disease programs at EASL
Premium
The Fly
Mirum announces new data from its rare liver disease programs at EASL
12d ago
MIRM
Mirum Pharmaceuticals Balances Rapid Growth and Heavy Spend
Premium
Company Announcements
Mirum Pharmaceuticals Balances Rapid Growth and Heavy Spend
23d ago
MIRM
Mirum Pharmaceuticals initiated with an Outperform at Wolfe Research
PremiumThe Fly
Mirum Pharmaceuticals initiated with an Outperform at Wolfe Research
24d ago
MIRM
Mirum Pharmaceuticals Issues $690 Million Convertible Senior Notes
PremiumCompany Announcements
Mirum Pharmaceuticals Issues $690 Million Convertible Senior Notes
25d ago
8K
MIRM
Mirum Pharmaceuticals announces $600M convertible senior notes offering
PremiumThe Fly
Mirum Pharmaceuticals announces $600M convertible senior notes offering
1M ago
MIRM
Mirum Pharmaceuticals price target raised to $165 from $164 at Raymond James
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $165 from $164 at Raymond James
1M ago
MIRM
Mirum Pharmaceuticals price target raised to $145 from $125 at TD Cowen
PremiumThe FlyMirum Pharmaceuticals price target raised to $145 from $125 at TD Cowen
1M ago
MIRM
Mirum Pharmaceuticals price target raised to $142 from $128 at RBC Capital
Premium
The Fly
Mirum Pharmaceuticals price target raised to $142 from $128 at RBC Capital
1M ago
MIRM
Mirum Pharmaceuticals price target raised to $129 from $112 at Baird
Premium
The Fly
Mirum Pharmaceuticals price target raised to $129 from $112 at Baird
1M ago
MIRM
Mirum Pharmaceuticals price target raised to $136 from $130 at Stifel
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $136 from $130 at Stifel
1M ago
MIRM
Mirum Pharmaceuticals price target raised to $138 from $135 at Evercore ISI
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $138 from $135 at Evercore ISI
1M ago
MIRM
Mirum Pharmaceuticals price target raised to $185 from $175 at H.C. Wainwright
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $185 from $175 at H.C. Wainwright
1M ago
MIRM
Mirum Pharmaceuticals reports Q1 EPS ($13.43), consensus (35c)
PremiumThe Fly
Mirum Pharmaceuticals reports Q1 EPS ($13.43), consensus (35c)
1M ago
MIRM
Mirum Pharmaceuticals Signals Growth Amid Heavy Investment
PremiumCompany AnnouncementsMirum Pharmaceuticals Signals Growth Amid Heavy Investment
1M ago
MIRM
Mirum Pharmaceuticals price target raised to $140 from $130 at Morgan Stanley
Premium
The Fly
Mirum Pharmaceuticals price target raised to $140 from $130 at Morgan Stanley
1M ago
MIRM
Mirum Pharmaceuticals price target raised to $175 from $150 at H.C. Wainwright
Premium
The Fly
Mirum Pharmaceuticals price target raised to $175 from $150 at H.C. Wainwright
1M ago
MIRM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >